Related Articles
Comparison of the effects of crizotinib as monotherapy and as combination therapy with butyric acid on different breast cancer cells
The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer
Trastuzumab enhances the anti-tumor effects of the histone deacetylase inhibitor sodium butyrate on a HER2-overexpressing breast cancer cell line
Co-treatment with gemcitabine and nab-paclitaxel exerts additive effects on pancreatic cancer cell death
PARP inhibition sensitizes endometrial cancer cells to paclitaxel-induced apoptosis